|

Experimental Group Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 4: 1Phase 2/3: 1

Top Sponsors

  • The First Hospital of Jilin University1
  • Anhui Provincial Hospital1

Indications

Other2 trials

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria
Phase 2/3
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.